GPT and metabolic dysfunction-associated steatotic liver disease: The observed, albeit mild, increases in both AST and ALT levels in the NAFLD cohort confirm the presence of ongoing hepatocellular injury, which aligns with the inflammatory nature of the disease, even if these markers are not fully diagnostic.